SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Leboyer Marion) "

Sökning: WFRF:(Leboyer Marion)

  • Resultat 21-30 av 64
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  • Coombes, Brandon J, et al. (författare)
  • Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study.
  • 2021
  • Ingår i: Complex psychiatry. - : S. Karger AG. - 2673-3005 .- 2673-298X. ; 7:3-4, s. 80-89
  • Tidskriftsartikel (refereegranskat)abstract
    • Response to lithium varies widely between individuals with bipolar disorder (BD). Polygenic risk scores (PRSs) can uncover pharmacogenomics effects and may help predict drug response. Patients (N = 2,510) with BD were assessed for long-term lithium response in the Consortium on Lithium Genetics using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder score. PRSs for attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), and schizophrenia (SCZ) were computed using lassosum and in a model including all three PRSs and other covariates, and the PRS of ADHD (β = -0.14; 95% confidence interval [CI]: -0.24 to -0.03; p value = 0.010) and MDD (β = -0.16; 95% CI: -0.27 to -0.04; p value = 0.005) predicted worse quantitative lithium response. A higher SCZ PRS was associated with higher rates of medication nonadherence (OR = 1.61; 95% CI: 1.34-1.93; p value = 2e-7). This study indicates that genetic risk for ADHD and depression may influence lithium treatment response. Interestingly, a higher SCZ PRS was associated with poor adherence, which can negatively impact treatment response. Incorporating genetic risk of ADHD, depression, and SCZ in combination with clinical risk may lead to better clinical care for patients with BD.
  •  
22.
  • de Pierrefeu, Amicie, et al. (författare)
  • Identifying a neuroanatomical signature of schizophrenia, reproducible across sites and stages, using machine-learning with structured sparsity
  • 2018
  • Ingår i: Acta Psychiatrica Scandinavica. - : John Wiley & Sons. - 0001-690X .- 1600-0447. ; 138, s. 571-580
  • Tidskriftsartikel (refereegranskat)abstract
    • ObjectiveStructural MRI (sMRI) increasingly offers insight into abnormalities inherent to schizophrenia. Previous machine learning applications suggest that individual classification is feasible and reliable and, however, is focused on the predictive performance of the clinical status in cross‐sectional designs, which has limited biological perspectives. Moreover, most studies depend on relatively small cohorts or single recruiting site. Finally, no study controlled for disease stage or medication's effect. These elements cast doubt on previous findings’ reproducibility.MethodWe propose a machine learning algorithm that provides an interpretable brain signature. Using large datasets collected from 4 sites (276 schizophrenia patients, 330 controls), we assessed cross‐site prediction reproducibility and associated predictive signature. For the first time, we evaluated the predictive signature regarding medication and illness duration using an independent dataset of first‐episode patients.ResultsMachine learning classifiers based on neuroanatomical features yield significant intersite prediction accuracies (72%) together with an excellent predictive signature stability. This signature provides a neural score significantly correlated with symptom severity and the extent of cognitive impairments. Moreover, this signature demonstrates its efficiency on first‐episode psychosis patients (73% accuracy).ConclusionThese results highlight the existence of a common neuroanatomical signature for schizophrenia, shared by a majority of patients even from an early stage of the disorder.
  •  
23.
  • De Pierrefeu, Amicie, et al. (författare)
  • Interpretable and stable prediction of schizophrenia on a large multisite dataset using machine learning with structured sparsity
  • 2018
  • Ingår i: 2018 International Workshop on Pattern Recognition in Neuroimaging (PRNI). - : IEEE. - 9781538668597
  • Konferensbidrag (refereegranskat)abstract
    • The use of machine-learning (ML) in neuroimaging offers new perspectives in early diagnosis and prognosis of brain diseases. Indeed, ML algorithms can jointly examine all brain features to capture complex relationships in the data in order to make inferences at a single-subject level. To deal with such high dimensional input and the associated risk of overfitting on the training data, a proper regularization (or feature selection) is required. Standard ℓ2-regularized predictors, such as Support Vector Machine, provide dense patterns of predictors. However, in the context of predictive disease signature discovery, it is now essential to understand the brain pattern that underpins the prediction. Despite ℓ1-regularized (sparse) has often been advocated as leading to more interpretable models, they generally lead to scattered and unstable patterns. We hypothesize that the integration of prior knowledge regarding the structure of the input images should improve the relevance and the stability of the predictive signature. Such structured sparsity can be obtained by combining together ℓ1 (possibly ℓ2) and Total variation (TV) penalties. We demonstrated the relevance of using ML with structured sparsity on a large multisite dataset of schizophrenia patients and controls. Using 3D maps of grey matter density, we obtained promising inter-site prediction performances. More importantly, we have uncovered a predictive signature of schizophrenia that is clinically interpretable and stable across resampling. This suggests that structured sparsity provides a major breakthrough over 'off-The-shelf' algorithms to perform a robust selection of important brain regions in the context of biomarkers discovery.
  •  
24.
  • Delorme, Richard, et al. (författare)
  • Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls.
  • 2010
  • Ingår i: BMC Medical Genetics. - : Springer Science and Business Media LLC. - 1471-2350. ; 11:1:108
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (NOS1AP) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of NOS1AP in these psychiatric conditions, but only a limited number explored the sequence variability of NOS1AP. METHODS: We analyzed the coding sequence of NOS1AP in a large population (n = 280), including patients with schizophrenia (n = 72), ASD (n = 81) or OCD (n = 34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n = 93). RESULTS: Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions. CONCLUSIONS: Coding variations of NOS1AP are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human NOS1AP gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders.
  •  
25.
  • Delorme, Richard, et al. (författare)
  • No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects.
  • 2006
  • Ingår i: Biological Psychiatry. - : Elsevier BV. - 0006-3223. ; 60:2, s. 202-203
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: It was recently reported that a rare functional variant, R441H, in the human tryptophan hydroxylase-2 gene (hTPH2) could represent an important risk factor for unipolar major depression (UP) since it was originally found in 10% of UP patients (vs. 1.4% in control subjects). METHODS: We explored the occurrence of this variation in patients with affective disorders (n = 646), autism spectrum disorders (n = 224), and obsessive-compulsive disorder (OCD) (n = 201); in healthy volunteers with no psychiatric disorders (n = 246); and in an ethnic panel of control individuals from North Africa, Sub-Saharan Africa, India, China, and Sweden (n = 277). RESULTS: Surprisingly, we did not observe the R441H variant in any of the individuals screened (3188 independent chromosomes). CONCLUSIONS: Our results do not confirm the role of the R441H mutation of the hTPH2 gene in the susceptibility to UP. The absence of the variant from a large cohort of psychiatric patients and control subjects suggests that the findings reported in the original study could be due to a genotyping error or to stratification of the initial population reported. Additional data by other groups should contribute to the clarification of the discrepancy between our results and those previous published.
  •  
26.
  • Delorme, Richard, et al. (författare)
  • Progress toward treatments for synaptic defects in autism.
  • 2013
  • Ingår i: Nature Medicine. - : Springer Science and Business Media LLC. - 1078-8956 .- 1546-170X. ; 19:6, s. 685-694
  • Tidskriftsartikel (refereegranskat)abstract
    • Autism spectrum disorder (ASD) encompasses a range of disorders that are characterized by social and communication deficits and repetitive behaviors. For the majority of affected individuals, the cause of ASD remains unknown, but in at least 20% of the cases, a genetic cause can be identified. There is currently no cure for ASD; however, results from mouse models indicate that some forms of the disorder could be alleviated even at the adult stage. Genes involved in ASD seem to converge on common pathways altering synaptic homeostasis. We propose, given the clinical heterogeneity of ASD, that specific 'synaptic clinical trials' should be designed and launched with the aim of establishing whether phenotype 'reversals' could also occur in humans.
  •  
27.
  •  
28.
  • Depienne, Christel, et al. (författare)
  • Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders.
  • 2009
  • Ingår i: Biological Psychiatry. - : Elsevier BV. - 0006-3223. ; 66:4, s. 349-359
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Maternally derived duplications of the 15q11-q13 region are the most frequently reported chromosomal aberrations in autism spectrum disorders (ASD). Prader-Willi and Angelman syndromes, caused by 15q11-q13 deletions or abnormal methylation of imprinted genes, are also associated with ASD. However, the prevalence of these disorders in ASD is unknown. The aim of this study was to assess the frequency of 15q11-q13 rearrangements in a large sample of patients ascertained for ASD. METHODS: A total of 522 patients belonging to 430 families were screened for deletions, duplications, and methylation abnormalities involving 15q11-q13 with multiplex ligation-dependent probe amplification (MLPA). RESULTS: We identified four patients with 15q11-q13 abnormalities: a supernumerary chromosome 15, a paternal interstitial duplication, and two subjects with Angelman syndrome, one with a maternal deletion and the other with a paternal uniparental disomy. CONCLUSIONS: Our results show that abnormalities of the 15q11-q13 region are a significant cause of ASD, accounting for approximately 1% of cases. Maternal interstitial 15q11-q13 duplications, previously reported to be present in 1% of patients with ASD, were not detected in our sample. Although paternal duplications of chromosome 15 remain phenotypically silent in the majority of patients, they can give rise to developmental delay and ASD in some subjects, suggesting that paternally expressed genes in this region can contribute to ASD, albeit with reduced penetrance compared with maternal duplications. These findings indicate that patients with ASD should be routinely screened for 15q genomic imbalances and methylation abnormalities and that MLPA is a reliable, rapid, and cost-effective method to perform this screening.
  •  
29.
  • Docherty, Anna R, et al. (författare)
  • GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
  • 2023
  • Ingår i: The American journal of psychiatry. - : American Psychiatric Association Publishing. - 1535-7228 .- 0002-953X. ; 180:10, s. 723-738
  • Tidskriftsartikel (refereegranskat)abstract
    • Suicidal behavior is heritable and is a major cause of death worldwide. Two large-scale genome-wide association studies (GWASs) recently discovered and cross-validated genome-wide significant (GWS) loci for suicide attempt (SA). The present study leveraged the genetic cohorts from both studies to conduct the largest GWAS meta-analysis of SA to date. Multi-ancestry and admixture-specific meta-analyses were conducted within groups of significant African, East Asian, and European ancestry admixtures.This study comprised 22 cohorts, including 43,871 SA cases and 915,025 ancestry-matched controls. Analytical methods across multi-ancestry and individual ancestry admixtures included inverse variance-weighted fixed-effects meta-analyses, followed by gene, gene-set, tissue-set, and drug-target enrichment, as well as summary-data-based Mendelian randomization with brain expression quantitative trait loci data, phenome-wide genetic correlation, and genetic causal proportion analyses.Multi-ancestry and European ancestry admixture GWAS meta-analyses identified 12 risk loci at p values <5×10-8. These loci were mostly intergenic and implicated DRD2, SLC6A9, FURIN, NLGN1, SOX5, PDE4B, and CACNG2. The multi-ancestry SNP-based heritability estimate of SA was 5.7% on the liability scale (SE=0.003, p=5.7×10-80). Significant brain tissue gene expression and drug set enrichment were observed. There was shared genetic variation of SA with attention deficit hyperactivity disorder, smoking, and risk tolerance after conditioning SA on both major depressive disorder and posttraumatic stress disorder. Genetic causal proportion analyses implicated shared genetic risk for specific health factors.This multi-ancestry analysis of suicide attempt identified several loci contributing to risk and establishes significant shared genetic covariation with clinical phenotypes. These findings provide insight into genetic factors associated with suicide attempt across ancestry admixture populations, in veteran and civilian populations, and in attempt versus death.
  •  
30.
  • Durand, Christelle M, et al. (författare)
  • Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders.
  • 2006
  • Ingår i: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics. - : Wiley. - 1552-4841. ; 141:1, s. 67-70
  • Tidskriftsartikel (refereegranskat)abstract
    • Synaptogenesis, the formation of functional synapses, is a crucial step for the development of the central nervous system. Among the genes involved in this process are cell adhesion molecules, such as protocadherins and neuroligins, which are essential factors for the identification of the appropriate partner cell and the formation of synapses. In this work, we studied the expression and the genetic variability of two closely related members of the protocadherin family PCDH11X/Y, located on the X and the Y chromosome, respectively. PCDH11Y is one of the rare genes specific to the hominoid lineage, being absent in other primates. Expression analysis indicated that transcripts of the PCDH11X/Y genes are mainly detected in the cortex of the human brain. Mutation screening of 30 individuals with autism identified two PCDH11Y polymorphic amino acid changes, F885V and K980N. These variations are in complete association, appeared during human evolution approximately 40,000 years ago and represent informative polymorphisms to study Y chromosome variability in populations. We studied the frequency of these variants in males with autism spectrum disorders (n = 110), attention deficit hyperactivity disorder (ADHD; n = 61), bipolar disorder (n = 61), obsessive-compulsive disorder (n = 51), or schizophrenia (n = 61) and observed no significant differences when compared to ethnically-matched control populations. These findings do not support the role of PCDH11Y, or more generally of a frequent specific Y chromosome, in the susceptibility to these neuropsychiatric disorders.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 64
Typ av publikation
tidskriftsartikel (57)
annan publikation (4)
forskningsöversikt (2)
konferensbidrag (1)
Typ av innehåll
refereegranskat (60)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Leboyer, Marion (64)
Gillberg, Christophe ... (43)
Jamain, Stéphane (20)
Råstam, Maria, 1948 (18)
Forstner, Andreas J (17)
Landén, Mikael, 1966 (16)
visa fler...
Bellivier, Frank (16)
Cichon, Sven (16)
Grigoroiu-Serbanescu ... (16)
Hauser, Joanna (16)
Alda, Martin (15)
Anckarsäter, Henrik, ... (15)
Hoffmann, Per (15)
Degenhardt, Franzisk ... (14)
Gillberg, I Carina, ... (13)
Monteleone, Palmiero (13)
Rouleau, Guy A. (13)
Etain, Bruno (13)
Herms, Stefan (13)
Kahn, Jean-Pierre (13)
Tortorella, Alfonso (13)
Mitchell, Philip B (12)
Vieta, Eduard (12)
Lavebratt, Catharina (12)
Schalling, Martin (12)
Heilbronner, Urs (12)
Hou, Liping (12)
Shekhtman, Tatyana (12)
Adli, Mazda (12)
Akula, Nirmala (12)
Ardau, Raffaella (12)
Arias, Bárbara (12)
Aubry, Jean-Michel (12)
Backlund, Lena (12)
Bengesser, Susanne (12)
Cervantes, Pablo (12)
Chillotti, Caterina (12)
Cruceanu, Cristiana (12)
Falkai, Peter (12)
Frisén, Louise (12)
Gard, Sébastien (12)
Jiménez, Esther (12)
Kassem, Layla (12)
Kuo, Po-Hsiu (12)
Kittel-Schneider, Sa ... (12)
Laje, Gonzalo (12)
Manchia, Mirko (12)
Martinsson, Lina (12)
Colom, Francesc (12)
Mitjans, Marina (12)
visa färre...
Lärosäte
Göteborgs universitet (59)
Karolinska Institutet (20)
Lunds universitet (17)
Umeå universitet (5)
Uppsala universitet (2)
Språk
Engelska (64)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (62)
Naturvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy